Prospective Evaluation of Predictors for Organ Failure Following Liver Transplantation
Completed
- Conditions
- Liver Transplantation
- Registration Number
- NCT00408889
- Lead Sponsor
- Heidelberg University
- Brief Summary
Early organ failure occurs frequently and is difficult to predict. The study aims to define a predictive score for early transplant failure.
- Detailed Description
Patients will be monitored 7 days following liver transplantation, including clinical scores, clinical chemistry, ultrasound findings and indocyaninegreen-clearance.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- orthotopic liver transplantation
- age > 18 years
Exclusion Criteria
- allergy to indocyangreen
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms contribute to early organ failure after liver transplantation?
How effective are current standard-of-care treatments in preventing post-transplant organ failure compared to novel predictive models?
Which biomarkers are most reliable for predicting early transplant failure in liver recipients?
What adverse events are commonly associated with liver transplantation and how are they managed?
Are there specific compounds or combination therapies that improve outcomes in liver transplant patients with high predictive failure scores?
Trial Locations
- Locations (1)
University Hospital of Heidelberg
🇩🇪Heidelberg, Germany
University Hospital of Heidelberg🇩🇪Heidelberg, Germany